Cargando…

Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking

The antiarrhythmic drug amiodarone delays cardiac repolarisation through inhibition of hERG-encoded potassium channels responsible for the rapid delayed rectifier potassium current (I(Kr)). This study aimed to elucidate molecular determinants of amiodarone binding to the hERG channel. Whole-cell pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yihong, Colenso, Charlotte K., El Harchi, Aziza, Cheng, Hongwei, Witchel, Harry J., Dempsey, Chris E., Hancox, Jules C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959829/ https://www.ncbi.nlm.nih.gov/pubmed/27256139 http://dx.doi.org/10.1016/j.bcp.2016.05.013

Ejemplares similares

Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants
por: Du, Chunyun, et al.
Publicado: (2014)

Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide
por: Melgari, Dario, et al.
Publicado: (2015)

Inhibition of the hERG Potassium Channel by a Methanesulphonate-Free E-4031 Analogue
por: Helliwell, Matthew V., et al.
Publicado: (2023)

Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration
por: Melgari, Dario, et al.
Publicado: (2014)

Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
por: Zhang, Yihong, et al.
Publicado: (2020)

hERG Potassium Channel Blockade by the HCN Channel Inhibitor Bradycardic Agent Ivabradine
por: Melgari, Dario, et al.
Publicado: (2015)

The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine
por: El Harchi, Aziza, et al.
Publicado: (2020)

Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition
por: Du, Chunyun, et al.
Publicado: (2013)

Assessing hERG Pore Models As Templates for Drug Docking Using Published Experimental Constraints: The Inactivated State in the Context of Drug Block
por: Dempsey, Christopher E., et al.
Publicado: (2014)

Structural implications of hERG K(+) channel block by a high-affinity minimally structured blocker
por: Helliwell, Matthew V., et al.
Publicado: (2018)

Voltage Sensor Gating Charge Transfer in a hERG Potassium Channel Model
por: Colenso, Charlotte K., et al.
Publicado: (2014)

An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020)

The Basis for Low-affinity hERG Potassium Channel Block by Sotalol
por: Zhang, Yi Hong, et al.
Publicado: (2017)

In silico Exploration of Interactions Between Potential COVID-19 Antiviral Treatments and the Pore of the hERG Potassium Channel—A Drug Antitarget
por: Al-Moubarak, Ehab, et al.
Publicado: (2021)

Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant
por: Al-Moubarak, Ehab, et al.
Publicado: (2021)

Action Potential Clamp and Pharmacology of the Variant 1 Short QT Syndrome T618I hERG K(+) Channel
por: El Harchi, Aziza, et al.
Publicado: (2012)

The hERG K(+) channel S4 domain L532P mutation: Characterization at 37 °C
por: Zhang, Yi H., et al.
Publicado: (2011)

Potent hERG channel inhibition by sarizotan, an investigative treatment for Rett Syndrome
por: Cheng, Hongwei, et al.
Publicado: (2019)

Serine mutation of a conserved threonine in the hERG K(+) channel S6-pore region leads to loss-of-function through trafficking impairment
por: Al-Moubarak, Ehab, et al.
Publicado: (2020)

Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2019)

Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2018)

Pharmacological activation of the hERG K(+) channel for the management of the long QT syndrome: A review
por: El Harchi, Aziza, et al.
Publicado: (2022)

Evolutionary coupling analysis guides identification of mistrafficking-sensitive variants in cardiac K(+) channels: Validation with hERG
por: Zhang, Yihong, et al.
Publicado: (2022)

Increased Vulnerability of Human Ventricle to Re-entrant Excitation in hERG-linked Variant 1 Short QT Syndrome
por: Adeniran, Ismail, et al.
Publicado: (2011)

In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome
por: Whittaker, Dominic G., et al.
Publicado: (2019)

Identification of a proton sensor that regulates conductance and open time of single hERG channels
por: Wilson, Stacey L., et al.
Publicado: (2019)

hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome
por: McPate, M.J., et al.
Publicado: (2009)

An Insight into the Potassium Currents of hERG and Their Simulation
por: Guidelli, Rolando
Publicado: (2023)

Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
por: Lin, Min, et al.
Publicado: (2023)

The N-linker region of hERG1a upregulates hERG1b potassium channels
por: Johnson, Ashley A., et al.
Publicado: (2022)

Na(+) Permeation and Block of hERG Potassium Channels
por: Gang, Hongying, et al.
Publicado: (2006)

Stereoselective Inhibition of the hERG1 Potassium Channel
por: Grilo, Liliana Sintra, et al.
Publicado: (2010)

Voltage-Dependent Gating of hERG Potassium Channels
por: Cheng, Yen May, et al.
Publicado: (2012)

Ion Conduction through the hERG Potassium Channel
por: Ceccarini, Luisa, et al.
Publicado: (2012)

hERG Gating Microdomains Defined by S6 Mutagenesis and Molecular Modeling
por: Wynia-Smith, Sarah L., et al.
Publicado: (2008)

Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin
por: Duncan, R.S., et al.
Publicado: (2007)

Inhibition of hERG Potassium Channels by Celecoxib and Its Mechanism
por: Frolov, Roman V., et al.
Publicado: (2011)

Mechanism of C-type inactivation in the hERG potassium channel
por: Li, Jing, et al.
Publicado: (2021)

Regulation of Kv4.3 and hERG potassium channels by KChIP2 isoforms and DPP6 and response to the dual K(+) channel activator NS3623
por: Lainez, Sergio, et al.
Publicado: (2018)

Rapid Characterization of hERG Channel Kinetics II: Temperature Dependence
por: Lei, Chon Lok, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m8154nt5obd2ln1e6ooi3n5jne